Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:YMAB
DateTimeSourceHeadlineSymbolCompany
06/04/20219:15AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
06/04/20219:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
06/04/20219:05AMGlobeNewswire Inc.Y-mAbs Announces Frontline Data for DANYELZA® (naxitamab-gqgk) in High-Risk NeuroblastomaNASDAQ:YMABY mAbs Therapeutics Inc
06/04/20219:00AMGlobeNewswire Inc.Y-mAbs Announces Update on Omburtamab for DIPGNASDAQ:YMABY mAbs Therapeutics Inc
06/02/20214:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
06/02/20214:17PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:YMABY mAbs Therapeutics Inc
06/01/20214:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/26/20214:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/20/20214:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
05/20/202111:06AMTipRanksY-mAbs Signs Antibodies’ Distribution Deal With Adium; Street Says BuyNASDAQ:YMABY mAbs Therapeutics Inc
05/19/20214:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
05/19/20214:01PMGlobeNewswire Inc.Y-mAbs Enters into Exclusive Distribution Agreement with Adium Pharma S.A. for DANYELZA® (naxitamab-gqgk) and Omburtamab in ...NASDAQ:YMABY mAbs Therapeutics Inc
05/13/20219:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
05/13/20219:00AMGlobeNewswire Inc.Y-mAbs Announces Update on SADA TechnologyNASDAQ:YMABY mAbs Therapeutics Inc
05/06/20215:17PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:YMABY mAbs Therapeutics Inc
05/06/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
05/06/20214:01PMGlobeNewswire Inc.Y-mAbs Announces First Quarter Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
04/29/20214:01PMGlobeNewswire Inc.Y-mAbs to Announce First Quarter 2021 Financial and Operating Results on May 6, 2021NASDAQ:YMABY mAbs Therapeutics Inc
04/29/20219:00AMGlobeNewswire Inc.Y-mAbs Announces Data to be Presented at 2021 ASCO Annual MeetingNASDAQ:YMABY mAbs Therapeutics Inc
04/28/20217:34AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:YMABY mAbs Therapeutics Inc
04/28/20217:31AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:YMABY mAbs Therapeutics Inc
04/27/20214:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
04/27/20214:01PMGlobeNewswire Inc.Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines AgencyNASDAQ:YMABY mAbs Therapeutics Inc
04/20/202111:50AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:YMABY mAbs Therapeutics Inc
04/20/20219:00AMGlobeNewswire Inc.Y-mAbs Provides Regulatory Update on Omburtamab   NASDAQ:YMABY mAbs Therapeutics Inc
04/14/20215:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
04/12/20219:00AMGlobeNewswire Inc.Y-mAbs Announces GPA33-SADA Data Presented at AACRNASDAQ:YMABY mAbs Therapeutics Inc
04/09/202110:24AMTipRanksJPMorgan Says These 2 Stocks Could Surge Over 80%NASDAQ:YMABY mAbs Therapeutics Inc
03/17/20214:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
03/12/20215:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:YMABY mAbs Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMAB